Corporate Overview

Lorem ipsum dolor sit amet, consectetuer adipiscing elit, sed diam nonummy nibh euismod tincidunt ut laoreet dolore magna aliquam erat volutpat. Ut wisi enim ad minim veniam, quis nostrud exerci tation ullamcorper suscipit lobortis nisl ut aliquip ex ea commodo consequat.

News

July 1, 2020

Bolt Biotherapeutics Closes $93.5 Million Series C FinancingRead More

June 9, 2020

Bolt Biotherapeutics Announces Issuance of U.S. Patent for the BoltbodyTM ISACTechnology and its Lead Development Candidate, BDC-1001Read More

May 12, 2020

Bolt Biotherapeutics Appoints William P. Quinn as Chief Financial OfficerRead More

View All Press releases

Events

November 5, 2020

Lorem ipsum dolor sit amet, consectetuer adipiscing elit, sed diam nonummyRead More

December 10, 2020

Duis autem vel eum iriure dolor in hendrerit in velit esse molestie consequat, vel illum dolore eu feugiat nulla facilisis at vero erosRead More

January 12, 2021

Ut wisi enim ad minim veniam, quis nostrud exerci tation tation ullamcorperRead More

View All Upcoming Events